ARTA
CRL icon

A.R.T. Advisors’s Charles River Laboratories CRL Stock Holding History

A.R.T. Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,000
Closed -$917K – 262
2019
Q4 		$917K Buy
+6,000
New +$831K 0.05% 595
2019
Q1 		– Sell
-12,600
Closed -$1.43M – 1356
2018
Q4 		$1.43M Buy
+12,600
New +$1.58M 0.09% 327
2017
Q4 		– Sell
-10,000
Closed -$1.08M – 1419
2017
Q3 		$1.08M Buy
+10,000
New +$1.03M 0.06% 498
2017
Q2 		– Sell
-6,900
Closed -$620K – 1462
2017
Q1 		$620K Sell
6,900
-2,000
-22% -$170K 0.03% 733
2016
Q4 		$678K Buy
+8,900
New +$676K 0.04% 622
2016
Q3 		– Sell
-36,114
Closed -$2.98M – 745
2016
Q2 		$2.98M Buy
36,114
+1,400
+4% +$115K 0.15% 193
2016
Q1 		$2.64M Buy
34,714
+12,500
+56% +$925K 0.12% 241
2015
Q4 		$1.78M Buy
22,214
+16,700
+303% +$1.2M 0.08% 332
2015
Q3 		$350K Buy
+5,514
New +$396K 0.01% 992
2014
Q4 		– Sell
-9,115
Closed -$544K – 1450
2014
Q3 		$544K Sell
9,115
-25,835
-74% -$1.48M 0.03% 713
2014
Q2 		$1.87M Buy
34,950
+11,630
+50% +$638K 0.1% 300
2014
Q1 		$1.41M Buy
23,320
+16,410
+237% +$957K 0.07% 368
2013
Q4 		$366K Buy
6,910
+821
+13% +$41.2K 0.02% 904
2013
Q3 		$281K Sell
6,089
-47,118
-89% -$2.16M 0.02% 1001
2013
Q2 		$2.18M Buy
+53,207
New +$2.28M 0.07% 382

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

A.R.T. Advisors's CRL Position: Q1 2020 in Review

A.R.T. Advisors sold out of Charles River Laboratories (CRL) in Q1 2020, closing a stake of 6,000 shares — an estimated $917K sold.

A.R.T. Advisors first reported a position in CRL in Q2 2013 and held it in 15 quarters. The position peaked at $2.98M in Q2 2016. 414 funds tracked by Wall St. Rank hold CRL as of Q1 2020.

  • A.R.T. Advisors reported no remaining Charles River Laboratories position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 6,000 Charles River Laboratories shares in Q1 2020, an estimated $917K.
  • A.R.T. Advisors first reported a position in Charles River Laboratories in Q2 2013 and held it in 15 quarters.
  • A.R.T. Advisors's Charles River Laboratories position peaked at $2.98M in Q2 2016.
  • 414 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.